Follow the people · Insider
Andrew M. Dahl
Andrew M. Dahl files insider transactions with the SEC as a svp, corporate controller of Edwards Lifesciences (EW). We hold 2 disclosed purchases and sales filed since 16 September 2024, 1 of them in the last 90 days.
- Files forEW
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure31 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 September 2024 — 31 August 2026SVP, Corporate Controller · Edwards Lifesciences (EW)14 Form 4 lines · source: SEC Form 4
Everything they disclosed
14 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 544 shares of Edwards LifesciencesSEC Form 431 August 2026Common Stock · traded 31 August 2026 · filed 31 August 2026
- ▼ sold on the open market 568 shares of Edwards LifesciencesSEC Form 429 May 2026Common Stock · traded 29 May 2026 · filed 29 May 2026
- was granted 3,985 shares of Edwards LifesciencesSEC Form 48 May 2026Common Stock · traded 7 May 2026 · filed 8 May 2026
- was granted 3,020 shares of Edwards LifesciencesSEC Form 48 May 2026Common Stock · traded 7 May 2026 · filed 8 May 2026
- had shares withheld for tax on 289 shares of Edwards LifesciencesSEC Form 48 May 2026Common Stock · traded 8 May 2026 · filed 8 May 2026
- was granted 6,745 shares of Edwards Lifesciences (a derivative holding)SEC Form 48 May 2026Employee Stock Option (Right to Acquire) · traded 7 May 2026 · filed 8 May 2026
- had shares withheld for tax on 176 shares of Edwards LifesciencesSEC Form 423 February 2026Common Stock · traded 22 February 2026 · filed 23 February 2026
- had shares withheld for tax on 176 shares of Edwards LifesciencesSEC Form 423 February 2026Common Stock · traded 22 February 2026 · filed 23 February 2026
- was granted 1,160 shares of Edwards LifesciencesSEC Form 413 November 2025Common Stock · traded 13 November 2025 · filed 13 November 2025
- had shares withheld for tax on 262 shares of Edwards LifesciencesSEC Form 415 September 2025Common Stock · traded 13 September 2025 · filed 15 September 2025
- was granted 5,670 shares of Edwards Lifesciences (a derivative holding)SEC Form 49 May 2025Employee Stock Option (Right to Acquire) · traded 8 May 2025 · filed 9 May 2025
- was granted 3,335 shares of Edwards LifesciencesSEC Form 49 May 2025Common Stock · traded 8 May 2025 · filed 9 May 2025
- had shares withheld for tax on 176 shares of Edwards LifesciencesSEC Form 424 February 2025Common Stock · traded 22 February 2025 · filed 24 February 2025
- was granted 2,920 shares of Edwards LifesciencesSEC Form 416 September 2024Common Stock · traded 13 September 2024 · filed 16 September 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.